SEC Form 4 · accession 0001574774-18-000031
BIOTELEMETRY, INC. · BEAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Wisniewski
Officer — SVP, Technical Operations
Period of report
May 7, 2018
Accepted (ET)
May 8, 2018 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001574774
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 7, 2018 | M | 40,000 | $4.24 | A | 66,291 | D | |
| Common StockF1 | May 7, 2018 | S | 40,000 | $41.09 | D | 26,291 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F2 | $4.24 | May 7, 2018 | M | 40,000 | D | — | Dec 6, 2020 | Common Stock | 40,000 | 60,000 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $41.00 to $41.30, inclusive. The reporting person undertakes to provide to BioTelemetry, Inc., any security holder of BioTelemetry, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- F2The stock options vested in four equal annual installments which began on December 6, 2011. The options were fully exercisable as of December 6, 2014.